Joint pain during GLP-1 treatment may result from rapid weight loss altering biomechanical loading on joints, increased physical activity levels, or pre-existing musculoskeletal conditions such as osteoarthritis, which are common in people with type 2 diabetes or obesity
They reduce sensations of hunger, and also seem to reduce impulsive human behaviour like binge-eating calorie dense foods
Researchers conducted a retrospective population-based study using data from over one million patients with diabetes in Ontario, Canada
evaluated liraglutide in 15 patients (11 with RA, 4 with PsA) with T2DM and active arthritis
For the most recent month-end and standardized performance, please call 646-661-5441 or visit the Funds website: We see several powerful tailwinds underpinning the GLP-1 and weight-loss drug revolution: Market leaders are grappling to take share and deliver strong growth, reflected in both expanding revenue and strong equity performance
This hormone is released during digestion, and help regulate blood sugar and appetite
